Dia-Präsentation von Merck Gesellschaft mbH. Micardis(R) - Micardis Plus(R) - Pharmakologie (14 Abbildungen) Übersicht
| ||||||||||||||||||
Abbildung 6: Angiotensin-I-Rezeptorblocker - Verteilungsvolumina Telmisartan also has the largest volume of distribution of any ARB.1 A large volume of distribution signifies that telmisartan penetrates the tissue compartment, ensuring that local as well as systemic RAAS is blocked. Because the AT1 receptor has pathological effects that include cell hypertrophy and fibrosis, blocking AT1 at the tissue level may help to reduce target-organ damage. 1. Song JC, White CM. Olmesartan medoxomil (CS-866). An angiotensin II receptor blocker for treatment of hypertension. Formulary 2001; 36: 487–499. |
![]()
Abbildung 6: Angiotensin-I-Rezeptorblocker - Verteilungsvolumina
Telmisartan also has the largest volume of distribution of any ARB.1 A large volume of distribution signifies that telmisartan penetrates the tissue compartment, ensuring that local as well as systemic RAAS is blocked. Because the AT1 receptor has pathological effects that include cell hypertrophy and fibrosis, blocking AT1 at the tissue level may help to reduce target-organ damage. 1. Song JC, White CM. Olmesartan medoxomil (CS-866). An angiotensin II receptor blocker for treatment of hypertension. Formulary 2001; 36: 487–499. |